Grepafloxacin
| 220px | |
| Grepafloxacin
| |
| Systematic (IUPAC) name | |
| 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline- 3-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H22FN3O3 |
| Mol. mass | 359.395 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 50% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Grepafloxacin | |
|
Articles | |
|---|---|
|
Most recent articles on Grepafloxacin Most cited articles on Grepafloxacin | |
|
Media | |
|
Powerpoint slides on Grepafloxacin | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Grepafloxacin at Clinical Trials.gov Trial results on Grepafloxacin Clinical Trials on Grepafloxacin at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Grepafloxacin NICE Guidance on Grepafloxacin
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Grepafloxacin Discussion groups on Grepafloxacin Patient Handouts on Grepafloxacin Directions to Hospitals Treating Grepafloxacin Risk calculators and risk factors for Grepafloxacin
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Grepafloxacin | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Grepafloxacin hydrochloride (Raxar®, Glaxo Wellcome) is an oral broad-spectrum quinoline antibacterial agent used to treat bacterial infections. Grepafloxacin was withdrawn in the United States due to its side effect of lengthening the QT interval on the electrocardiogram, leading to cardiac events and sudden death.
Antibacterials for systemic use: topoisomerase inhibitors - quinolones (J01M) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fluoroquinolones |
| ||||||||
| Other quinolones |
| ||||||||
| †Undergoing clinical trials. ‡ Withdrawn from market. § Veterinary use medications. | |||||||||
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies